Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis.

allergic inflammation asthma atopic dermatitis biomarkers eosinophils neutrophils

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 26 07 2021
accepted: 20 09 2021
entrez: 18 10 2021
pubmed: 19 10 2021
medline: 19 10 2021
Statut: epublish

Résumé

In the last years, the understanding of the pathologic mechanisms of asthma and atopic dermatitis, both characterized by allergic inflammation, has greatly improved. However, it is evident that both diseases present with high heterogeneity, which complicates the diagnosis and the therapeutic approach of the patients. Moreover, some of the currently available strategies to treat asthma and atopic dermatitis are still mostly controlling the symptoms, but not to lead towards full healing, thus having these two diseases labelled as unmet clinical needs by WHO. Therefore, the "one-size-fits-all" strategy is outdated for asthma and atopic dermatitis, and there is the need of better methods to clearly diagnose the disease and tailor the therapy according to the specific symptomatology. In this regard, the use of biomarkers has been advanced in order to characterize both diseases according to their clinical signs and to facilitate the subsequent treatment. Despite the advancements made in this regard, there is still need for better and more sensitive biomarkers and for less invasive sampling methodologies, with the aim to diagnose specifically each manifestation of asthma and atopic dermatitis and to provide the best treatment with the least suffering for the patients.

Identifiants

pubmed: 34658882
doi: 10.3389/fphar.2021.747364
pii: 747364
pmc: PMC8514744
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

747364

Informations de copyright

Copyright © 2021 Puzzovio and Levi-Schaffer.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Allergy Clin Immunol. 2016 Nov;138(5):1473-1477.e5
pubmed: 27450726
J Allergy Clin Immunol. 2008 Jan;121(1):5-10; quiz 11-2
pubmed: 18036647
Thorax. 2015 Aug;70(8):748-56
pubmed: 26001563
Allergy. 2013 Feb;68(2):171-9
pubmed: 23205534
Proc Am Thorac Soc. 2009 May 1;6(3):301-5
pubmed: 19387034
Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Allergy. 2016 May;71(5):724-7
pubmed: 26835886
J Allergy Clin Immunol. 2020 Jan;145(1):215-228
pubmed: 31626841
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302
pubmed: 24200404
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1125-32
pubmed: 21852542
Sci Transl Med. 2013 Feb 27;5(174):174ra26
pubmed: 23447017
J Allergy Clin Immunol. 2016 Dec;138(6):1608-1618.e12
pubmed: 27777180
Nat Commun. 2019 Oct 16;10(1):4703
pubmed: 31619666
Allergy. 2019 Jul;74(7):1377-1380
pubmed: 30667087
Front Cell Dev Biol. 2020 Apr 02;8:223
pubmed: 32300593
Nat Rev Drug Discov. 2016 Aug;15(8):551-67
pubmed: 27020098
Respir Res. 2017 Feb 23;18(1):39
pubmed: 28231834
J Allergy Clin Immunol. 2016 Dec;138(6):1639-1651
pubmed: 27671162
N Engl J Med. 2004 Feb 5;350(6):560-9
pubmed: 14762183
J Immunol. 2005 Dec 15;175(12):7989-95
pubmed: 16339535
Thorax. 2007 Mar;62(3):211-8
pubmed: 16844729
Allergol Int. 2018 Oct;67(4):460-466
pubmed: 29605098
Allergy. 2019 Nov;74(11):2240-2243
pubmed: 31016745
JAMA Dermatol. 2019 Dec 1;155(12):1358-1370
pubmed: 31596431
Respirology. 2006 Jan;11(1):54-61
pubmed: 16423202
J Invest Dermatol. 2017 Mar;137(3):603-613
pubmed: 27825969
Allergy. 2018 Jun;73(6):1284-1293
pubmed: 29319189
N Engl J Med. 2013 Jun 27;368(26):2455-66
pubmed: 23688323
N Engl J Med. 2014 Sep 25;371(13):1198-207
pubmed: 25199059
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60
pubmed: 26226355
J Clin Med. 2020 Sep 04;9(9):
pubmed: 32899610
Pediatr Pulmonol. 2017 Dec;52(12):1616-1627
pubmed: 29082668
Lancet. 1958 Dec 13;2(7059):1245-7
pubmed: 13612182
J Allergy Clin Immunol. 2021 Jan;147(1):189-198
pubmed: 32526312
Eur Respir J. 2019 Nov 7;54(5):
pubmed: 31699782
Int Arch Allergy Immunol. 2001 Nov;126(3):179-84
pubmed: 11752873
J Allergy Clin Immunol. 2014 Mar;133(3):784-9
pubmed: 24184149
Metabolites. 2020 Sep 29;10(10):
pubmed: 33003349
Respir Med. 2013 Jan;107(1):37-46
pubmed: 23098685
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1497-500
pubmed: 7582283
Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L472-82
pubmed: 20639353
Am J Respir Crit Care Med. 2008 Sep 15;178(6):574-82
pubmed: 18583575
Clin Exp Allergy. 2014 Nov;44(11):1335-46
pubmed: 25255823
Allergy. 2019 Dec;74(12):2293-2311
pubmed: 31056763
Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15
pubmed: 21885636
J Allergy Clin Immunol. 2006 Nov;118(5):1082-9
pubmed: 17088133
J Allergy Clin Immunol. 2017 Oct;140(4):1004-1014.e13
pubmed: 28163052
Chest. 2012 Jul;142(1):86-93
pubmed: 22345378
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
J Clin Immunol. 1997 Nov;17(6):502-9
pubmed: 9418191
Immunol Lett. 2014 Nov;162(1 Pt A):2-10
pubmed: 25194755
J Am Acad Dermatol. 2014 Dec;71(6):1160-6
pubmed: 25199679
Respir Med. 2006 Aug;100(8):1392-6
pubmed: 16431095
Nat Immunol. 2015 Jan;16(1):45-56
pubmed: 25521684
J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):525-36.e1
pubmed: 25213045
Clin Exp Allergy. 2006 Nov;36(11):1373-81
pubmed: 17083347
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
J Clin Invest. 2019 Mar 11;129(4):1493-1503
pubmed: 30855278
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1840-1852
pubmed: 32499033
Lancet. 2016 Mar 12;387(10023):1109-1122
pubmed: 26377142
Am J Respir Crit Care Med. 2016 May 1;193(9):949-56
pubmed: 26756066
J Allergy Clin Immunol. 2021 Apr;147(4):1329-1340
pubmed: 33039480
Allergy. 2017 Jun;72(6):888-895
pubmed: 27859399
Lancet Respir Med. 2015 Nov;3(11):849-58
pubmed: 26493938
J Allergy Clin Immunol. 2015 Feb;135(2):299-310; quiz 311
pubmed: 25662302
Eur Respir J. 2019 Jan 3;53(1):
pubmed: 30606766
J Allergy Clin Immunol. 2015 Nov;136(5):1254-64
pubmed: 26428954
Trends Immunol. 2017 Dec;38(12):942-954
pubmed: 28784414
Lancet. 2016 Oct 29;388(10056):2128-2141
pubmed: 27609406
Respir Res. 2006 Nov 03;7:135
pubmed: 17083726
Allergy. 2019 Oct;74(10):1835-1851
pubmed: 30953574
J Allergy Clin Immunol. 2014 Jun;133(6):1557-63.e5
pubmed: 24332216
Clin Exp Allergy. 2012 Jul;42(7):1097-103
pubmed: 22702508
JAMA Dermatol. 2019 Dec 1;155(12):1342-1343
pubmed: 31596425
J Clin Med. 2015 Mar 16;4(3):479-87
pubmed: 26239250
J Allergy Clin Immunol. 2012 Sep;130(3):647-654.e10
pubmed: 22857879
J Allergy Clin Immunol. 2019 Jan;143(1):142-154
pubmed: 30121291
Eur Respir J. 2015 Sep;46(3):688-96
pubmed: 26113672
J Immunol Res. 2018 Sep 16;2018:4236263
pubmed: 30306094
JCI Insight. 2017 Jul 20;2(14):
pubmed: 28724795
Allergy. 2020 Dec;75(12):3124-3146
pubmed: 32997808
Curr Top Med Chem. 2016;16(14):1561-73
pubmed: 26467509
J Allergy Clin Immunol. 2005 Jun;115(6):1130-6
pubmed: 15940124
J Immunol. 2006 Jul 1;177(1):77-83
pubmed: 16785501
Am J Respir Crit Care Med. 2019 Aug 15;200(4):444-453
pubmed: 30973757
J Allergy Clin Immunol. 2006 Jun;117(6):1314-20
pubmed: 16750992
Lancet. 2002 Nov 30;360(9347):1715-21
pubmed: 12480423
Clin Exp Allergy. 2016 Oct;46(10):1291-302
pubmed: 27214328
Semin Immunol. 2019 Dec;46:101332
pubmed: 31735516
J Immunol Res. 2017;2017:3743048
pubmed: 29359169
J Allergy Clin Immunol. 2017 Apr;139(4S):S58-S64
pubmed: 28390478

Auteurs

Pier Giorgio Puzzovio (PG)

Pharmacology and Experimental Therapeutics Unit, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.

Francesca Levi-Schaffer (F)

Pharmacology and Experimental Therapeutics Unit, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.

Classifications MeSH